title: Clinical inquiries. What's the best way to monitor low-risk patients with a history of differentiated thyroid cancer?
abstract: Recombinant human thyrotropin (rhTSH)-stimulated serum thyroglobulin (Tg) level alone is sufficient to monitor for recurrent disease in low-risk patients with a history of differentiated thyroid cancer (DTC). Low-risk patients are defined as patients who have undergone total thyroidectomy and radioactive iodine (I(131)) remnant ablation therapy and show no clinical evidence of recurrent disease.
authors: Family Medicine Residency, Eglin Air Force Base, FL, USA.
authors: Angela M
authors: AM
authors: Albrecht
authors: Christopher P
authors: CP
authors: Paulson
authors: Fran E
authors: FE
authors: Kovach
mesh_terms: D042241:Early Diagnosis; D006801:Humans; D007457:Iodine Radioisotopes; D011237:Predictive Value of Tests; D011994:Recombinant Proteins; D012680:Sensitivity and Specificity; D013954:Thyroglobulin / Q000096:biosynthesis*; D013964:Thyroid Neoplasms / Q000175:diagnosis*; D013972:Thyrotropin
chemical_list: D007457:Iodine Radioisotopes; D011994:Recombinant Proteins; D013972:Thyrotropin; D013954:Thyroglobulin